Dergiler / Turkish Journal of Hematology / 2002 / Cilt: 19 - Sayı: 3

Stevens-Johnson syndrome-like exanthema secondary to methotrexate

Sayfa
427–430
DOI
—
🏛️Bu makalenin bibliyografik verileri ve tam metin bağlantısı DergiPark üzerinden sağlanmıştır.
DergiPark Kaydı ↗
✨

Yapay Zeka Hızlı Bakış & Çıkarımlar

AI Insight
⚡ TL;DR(1 Cümlede Hızlı Çıkarım)

The skin lesions simulated Stevens-Johnson syndrome with ulceration of the oral mucosa and erythema multiforme-like target lesions.

📌 3 Maddede Bu Makale

🎯
Amaç & Hipotez:Methotrexate is an antineoplastic drug used commonly in leukemia treatment.
📊
Temel Bulgular & Veri:Because of becoming resistant to standard doses after 1970s, it is used intermediate or high doses.
💡
Sonuç & Katkı:The skin lesions simulated Stevens-Johnson syndrome with ulceration of the oral mucosa and erythema multiforme-like target lesions.
🔬Tür:Araştırma Makalesi
📍Kapsam:Genişletilmiş Akademik Örneklem
⚙️Değişkenler:Nötropeni · Ölümle sonuçlanma · Stevens-Johnson sendromu

Özet

Methotrexate is an antineoplastic drug used commonly in leukemia treatment. Because of becoming resistant to standard doses after 1970s, it is used intermediate or high doses. The complications of high doses are mucositis, vomiting, dermatitis exfoliativa, B-cell dysfunction, hepatotoxicity, nephrotoxicity and bone marrow depression. There were only two studies in literature about Stevens-Johnson syndrome occuring in two patients with acute lymphocytic leukemia and non-Hodgkin lymphoma after receiving high doses methotrexate and leukoverin. We have reported a two-year-old boy patient suffering from acute lymphocytic leukemia (ALL) developed a severe skin reaction two days after administration of high dose methotrexate. The skin lesions simulated Stevens-Johnson syndrome with ulceration of the oral mucosa and erythema multiforme-like target lesions.

🔖

Bu Makaleye Atıf Yap

ATABEK, M. E., ÇALIŞKAN, Ü., PİRGON, Ö., TOL, H., ERKUL, İ. (2002). Stevens-Johnson syndrome-like exanthema secondary to methotrexate. Turkish Journal of Hematology, Cilt: 19 - Sayı: 3, 427–430. https://ajindex.com/articles/412998

📄 Tam Metin PDF Okuyucu

📄

PDF görüntüleyici hazırlanıyor...

Kaynakça (1)

  1. Darmstadt GL, Lane AL. Vesiculobullous disorders.In: Behrman RE, Kligman RM, Arvin AM, NelsonWE (eds). Nelson Textbook of Pediatrics. 16thed.Philadelphia: WB Saunders, 1996:1850-1. 2.Mahoney DH. Acute lymphoblastic leukemia. In:Mcmillan JA, Deangelis CD, Feigin RD, WarshawBJ (eds). Oski’s Pediatrics. Philadelphia: LippincotWilliams and Wilkins, 1999:1498-500. 3.Cohen DM, Bhattacharyya I. Cinnamon-inducedoral erythema multiformlike sensitivity reaction. JAm Dent Assoc 2000;131:929-34. 4.Cuthbert RJ, Criag JI, Ludlam CA. Stevens-John-son Syndrome associated with methotrexate treat-ment for non-Hodgkin’s lymphoma. Ulster Med J1993; 62:95-7. 5.Moe PJ, Seip M. High dose methotrexate acutelymphoblastic leukemia in childhood. Acta PaediatrScand 1978;67:256-8. 6.Green DM, Brecher ML, Blumenson LE, Grossi M,Freeman AI. The use of intermediate dose methot-rexate in increased risk childhood acute lymphob-lastic leukemia. A comparison of three versus sixcourses. Cancer 1982;50:2722-7. 7.Hani N, Casper C, Groth W, Krieg T, HunzelmannN. Stevens-Johnson syndrome-like exanthema se-condary to methotrexate histologically simulatingacute graft-versus-host disease. Eur J Dermatol2000;10:548-50.